secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0000950170-25-074374
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics receives Nasdaq delisting notice for bid price below $1.00
----------------------------------------------------------------------------

- Nasdaq notified Plus Therapeutics on May 16, 2025 of non-compliance with minimum bid price rule (closing bid < $1.00 for 30 consecutive days).
- Initial compliance period ends November 12, 2025; must close at $1.00+ for 10 consecutive business days.
- If not cured by Nov 12, may be eligible for additional 180-day period if meets other listing standards.
- Company will consider options including reverse stock split to regain compliance; no assurance of success.
- Potential delisting can be appealed; common stock continues trading on Nasdaq during process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000095017025074374/0000950170-25-074374-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000095017025074374/pstv-20250516.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-074374

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer